AB&B BIO-TECH-B (02627) has announced a suspension of trading for its shares. The halt will commence at 9:00 a.m. on Wednesday, April 1, 2026, on the Stock Exchange of Hong Kong. Trading will remain suspended until the company publishes its financial results for the full year ending 2025.